US › Healthcare

BioLife Solutions Inc (BLFS)

US · Healthcare · Medical Instruments & Supplies

$32.52+1.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$27.5M
Revenue YoY
+14.9%
Net profit
$1.2M
Profit YoY
+364.7%
EPS
$0.04
EPS estimate
$0.02
Net margin
4.3%

EPS came in at 0.04 against a street estimate of 0.02 — a beat of 100.0%.

Key statistics

Market cap
$1.57B
Forward P/E
270.3
P/B
4.11
Book value
$7.62
EPS (TTM)
$-0.24
52-week high
$33.14
52-week low
$17.86
50-day MA
$27.59
200-day MA
$24.40
Beta
1.90

Analyst view

Analysts rate BioLife Solutions Inc a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $31.25.

Shareholding

Insiders
2.37%
Institutions
104.05%

Largest institutional holders

FundStake
T. Rowe Price Investment Management,Inc.13.32%
BlackRock Inc12.49%
Casdin Capital, LLC12.19%
Vanguard Group Inc6.32%
Amvescap Plc.4.81%
Vanguard Capital Management, LLC3.93%
State Street Corp3.23%
FMR Inc3.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for BioLife Solutions Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.